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 We present the case of a man with a history of migraines 
treated with propanolol, referred with a rash, diarrhoea, 
vomiting and hypotension. Our case highlights how prior beta-
blocker use may prolong anaphylaxis and cause refractory 
hypotension. 
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 Case presentation 
 A 43-year-old male IT consultant presented to the accident and 
emergency department of the Royal Free Hospital with a new 
rash, vomiting, diarrhoea and profound postural hypotension 
unresponsive to fluids. He had a long history of migraines 
for which he was taking prophylactic propranolol; on the 
day prior to admission, he had received a repeat prescription 
of propranolol from a new manufacturer, which contained 
cellulose, and eaten a meal containing cooked salmon. 
 On review by the medical team, he reported some facial and 
finger swelling and dizziness on sitting. Examination revealed 
lip and finger swelling and a widespread urticarial rash over the 
trunk and limbs (Fig  1 ). Measurement of lying and sitting blood 
pressures revealed a postural drop in systolic blood pressure 
of greater than 50 mmHg. The remainder of the examination 
was unremarkable. His blood tests were normal apart from a 
neutrophilia (white blood cell count 12.69×10 9 /L, neutrophils 
10.89×109/L) and elevated C-reactive protein (19 mg/L rising to 
81 mg/L within 8 hours). 
 Differential diagnosis 
 This patient had been referred with refractory hypotension, 
diarrhoea and vomiting and a new rash, thought to 
be associated with a recent change in his beta-blocker 
manufacturer. His symptoms initially were thought to be due to 
viral gastroenteritis but this did not explain the new urticarial 
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rash. With this in mind, it was thought that he showed a delayed 
anaphylactic response to cellulose or scombroid poisoning 
from salmon ingestion the day before. During the course of his 
illness, he developed a fever and bacterial sepsis was considered 
as another differential diagnosis for his refractory hypotension. 
To confirm the diagnosis, we proceeded to measure the mast 
cell tryptase response and sent blood and stool for culture and 
viral polymerase chain reaction (PCR). 
 Case progression 
 Initially, the patient was treated with hydrocortisone, 
chlorpheniramine and intramuscular adrenaline (500 mcg 
of 1:1000 concentration). At first, he showed a good response 
with a reduction in facial swelling, fading of the rash and 
improvement in blood pressure. However, the response was 
limited and he subsequently experienced two further episodes 
of facial swelling and hypotension both requiring further doses 
of intramuscular adrenaline. 
 During the admission he developed a fever and intravenous 
ceftriaxone was commenced to treat potential bacterial sepsis, 
although subsequent blood cultures were negative. Further 
blood tests showed an initial rise in mast cell trypase (Fig  2 ) 
supporting a diagnosis of anaphylaxis rather than scombroid 
poisoning. Additionally, PCR of stool was positive for norovirus. 
 Fig 1.  Urticarial rash visible on the trunk. 
CMJv16n5-Lamb.indd   451 06/09/16   1:00 PM
Lucy Lamb and David Lowe
452 © Royal College of Physicians 2016. All rights reserved.
 Discussion 
 In this case report, we describe the delayed presentation and 
protracted reversal of an anaphylactic reaction in a patient 
treated with beta-blockers. We show how mast cell tryptase 
measurement can be useful in the follow-up of suspected 
anaphylactic reactions, although clinicians must be mindful 
that collection should not delay resuscitation. 1 It is likely in 
this case that the symptoms were exacerbated both by prior 
use of beta-blockers and a concomitant norovirus infection. 
Scombroid poisoning was considered as a differential diagnosis 
as it can lead to ‘allergic-like’ symptoms, including an urticarial 
rash, vomiting, diarrhoea and hypotension. This is a complex 
of symptoms caused by biogenic amines – mainly histamine – 
contained in seafood. However, it was felt that this was not 
the cause because it typically results in no significant rise in 
mast cell tryptase 2 and would usually affect all of the people 
who ingested the fish. We also considered whether this was a 
biphasic anaphylactic reaction but this was thought unlikely 
because of the failure to fully respond before requiring more 
treatment, the absence of a persistent or second rise in mast cell 
tryptase and complete resolution of symptoms within 36 hours. 
 Beta-blockers inhibit both the endogenous and exogenous 
administration of epinephrine leading to a more severe, 
protracted and difficult to treat anaphylaxis. 3 In our case, it 
appears that the patient experienced an allergic reaction to a 
new cellulose-containing beta-blocker preparation. He was 
slow to treat and resuscitate, plausibly because of a long-
standing history of beta-blocker use and gastroenteritis caused 
by norovirus infection. His management consisted of the 
administration of adrenaline and initiation of aggressive fluid 
resuscitation, 1 which in this case was successful. If adrenaline 
and fluids fail to restore the blood pressure, other agents like 
glucagon could be considered. 4–6 Patients who have suffered a 
suspected anaphylaxis should be observed closely and referred 
to an appropriate allergy service for follow-up. Adverse drug 
reactions should be reported to the Medicines and Healthcare 
products Regulatory Agency ( www.mhra.gov.uk ). Clinicians 
should also be aware of biphasic reactions (incidence ranges 
from 1–20%), a reoccurrence of symptoms within 72 hours 
following apparent complete recovery of anaphylaxis: 
management is the same as for the first episode. It has been 
suggested that patients should be observed for 24 hours after 
recovery in view of this possibility. 7–9 
 Key learning points 
>  Consider a delay in presentation of anaphylaxis and response 
to intramuscular adrenaline in patients who have been 
taking beta-blockers. 
>  Allergies to medicines may occur simply because of a change 
in manufacturer. 
 >  Mast cell tryptase levels may be used to diagnose acute 
anaphylaxis and exclude other differentials, like scombroid 
poisoning, but measurement should not delay treatment. 
 >  Consider other causes of refractory hypotension, including 
sepsis. 
>  Patients may require observation for up to 24 hours to 
exclude a biphasic reaction. ■ 
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 Fig 2.  Response seen by the mast cell tryptase during the course of the 
illness. 
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